|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.24 CNY | -5.36% |
|
-15.35% | +13.16% |
| 05-26 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| 05-25 | Guizhou Sanli pharmaceutical to raise funds via private placement | RE |
| Market Cap | 5.36B 788M 691M 637M 596M 1.12B 74.31B 1.14B 7.65B 2.96B 36.73B 2.96B 2.89B 127B | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 5.71B 839M 736M 678M 635M 1.19B 79.15B 1.22B 8.15B 3.15B 39.12B 3.15B 3.08B 136B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.74% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | -5.36% | ||
| 1 week | -15.35% | ||
| Current month | -18.67% | ||
| 1 month | -10.30% | ||
| 3 months | +22.59% | ||
| 6 months | +11.54% | ||
| Current year | +13.16% |
| 1 week | 13.2 | 16.25 | |
| 1 month | 13.2 | 17.46 | |
| Current year | 10.49 | 17.46 | |
| 1 year | 10.49 | 17.46 | |
| 3 years | 10.49 | 20.34 | |
| 5 years | 10.49 | 21.28 | |
| 10 years | 8.82 | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 27/05/2024 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 01/09/2011 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Shi Gui Chen
BRD | Director/Board Member | 63 | 12/12/2022 |
Wei Sheng Feng
BRD | Director/Board Member | 66 | 10/10/2024 |
Hai Zhang
CHM | Chairman | 41 | 01/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/09/24 | Sell | Chief Executive Officer | 21,000,000 | 5.1428% | ||
| 02/08/24 | Buy | Director | 13,000 | 0.0032% | ||
| 05/08/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.36% | -15.35% | +10.52% | -19.71% | 833M | ||
| +6.60% | +8.75% | +50.73% | +164.71% | 1,006B | ||
| +3.42% | +9.33% | +66.36% | +54.54% | 589B | ||
| +1.68% | +7.44% | +32.30% | +83.12% | 430B | ||
| -0.66% | +5.11% | +29.26% | +21.27% | 331B | ||
| +1.82% | +8.19% | +41.15% | +26.80% | 288B | ||
| +0.22% | +6.75% | +31.51% | +42.02% | 285B | ||
| +0.73% | +8.53% | -26.22% | -40.85% | 213B | ||
| +1.53% | +3.88% | +28.29% | +59.34% | 190B | ||
| +1.73% | +0.73% | +16.88% | +64.30% | 154B | ||
| Average | +1.06% | +3.94% | +28.08% | +45.55% | 348.66B | |
| Weighted average by Cap. | +2.89% | +5.37% | +39.27% | +78.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 315M 276M 255M 239M 447M 29.74B 457M 3.06B 1.18B 14.7B 1.18B 1.16B 50.96B | 1.7B 250M 219M 202M 189M 355M 23.61B 363M 2.43B 941M 11.67B 940M 919M 40.47B |
| Net income | 274M 40.28M 35.32M 32.56M 30.48M 57.16M 3.8B 58.34M 391M 151M 1.88B 151M 148M 6.51B | 46.25M 6.8M 5.96M 5.5M 5.14M 9.65M 641M 9.85M 66.05M 25.56M 317M 25.53M 24.97M 1.1B |
| Net Debt | 108M 15.83M 13.88M 12.79M 11.98M 22.46M 1.49B 22.92M 154M 59.49M 738M 59.43M 58.13M 2.56B | 349M 51.26M 44.95M 41.43M 38.79M 72.73M 4.84B 74.24M 498M 193M 2.39B 192M 188M 8.29B |
Employees
1,887
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | CN¥13.24 | -5.36% | 12,592,200 |
| 25/06/26 | CN¥13.99 | -4.96% | 14,323,300 |
| 24/06/26 | CN¥14.72 | -0.88% | 13,854,000 |
| 23/06/26 | CN¥14.85 | -3.76% | 17,286,900 |
| 22/06/26 | CN¥15.43 | -1.34% | 17,833,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
















